GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Summerlin North: Genesis Lifestyle Medicine, TrimBody M.D. Summerlin and Perpetual Health Group. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
For Summerlin North residents, the essentials on wegovy. Wegovy was designed from the start for weight management, with a target dose higher than Ozempic's - hence its dedicated indication.
Beyond the numbers, the evaluation factors in your history, current medications, and contraindications specific to the molecule. Eligibility rests mostly on BMI and comorbidities: a higher threshold on its own, or a lower one when an associated condition like prediabetes or hypertension is present.
With a local obesity rate around 30.6% and 11.0% uninsured, demand for Wegovy runs high around Summerlin North. In this state, Nevada Revised Statutes §629.515; the reference body is Nevada State Board of Medical Examiners. On the cost side, expect about $1,300-1,350/month brand-name without insurance; compounded semaglutide about $200-500/month. Wegovy belongs to the 'GLP-1 agonist (brand of semaglutide, weight indication)' class and is given as a weekly subcutaneous injection.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
Coverage varies widely by plan; without coverage, many patients compare it to compounded semaglutide, which is far cheaper.
It is the same molecule (semaglutide), but Wegovy goes up to 2.4 mg/week versus 2.0 mg max for Ozempic - a dose built for weight loss, which is why it is approved for that indication.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.